About Amicus Therapeutics

Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases.

Amicus Therapeutics is committed to providing quality medical education. The Amicus Education website has been developed to help UK healthcare professionals increase their knowledge of specific rare metabolic diseases, enabling them to support their patients. For more information please visit the company’s website at www.amicusrx.co.uk.